tanoyl-CoA is formed by the dehydrocondensation of the carboxy group in octanoic acid and the thiol group in CoA.
We previously identified inhibitors of octanoylated ghrelin production using the ghrelin-expressing cell line AGS-GHRL8 developed in our laboratory 12 . Using a cell based assay system, we found that oleanolic acid Fig. 1 , a triterpene contained in plants, such as grapes Vitis vinifera , pomegranate Punica granatum , and olive Olea europaea , reduces octanoylated ghrelin levels in AGS-GHRL8 cells 13 . Furthermore, β-amylin, a compound in which the carboxy group of oleanolic acid is substituted with a methyl group, does not inhibit octanoyl ghrelin production in AGS-GHRL8 cells and the carboxy group in oleanolic acid is crucial for the inhibition of octanoylated ghrelin production 13 .
In this study, we investigated whether the oral administration of oleanolic acid affects plasma octanoylated ghrelin levels, food intake, and body weight gain in C57/BL6J mice fed a standard, high-fat, or high-glucose diet. In addition, we evaluated the mRNA levels of ghrelin, GOAT, and PCs in mice treated with oleanolic acid and investigated whether oleanolic acid inhibits the production of octanoylCoA in vitro.
EXPERIMENTAL 2.1 Reagents and materials
Oleanolic acid was purchased from Tokyo Chemical Industry Co. Tokyo, Japan . Glucose and hydroxyethyl cellulose were obtained from Wako Pure Chemical Industries Osaka, Japan . Mix was purchased from Takara Bio Inc. Ohtsu, Japan . Primers targeting ghrelin, GOAT, furin, PC1/3, PC2, and 18S ribosomal RNA were synthesized by Genenet Fukuoka, Japan and Greiner Japan Kanagawa, Japan . Other reagents were obtained from Wako Pure Chemical Industries unless otherwise indicated.
Animals and experimental treatment
Male 6-week-old C57BL/6J mice were purchased from SLC Shizuoka, Japan . The mice were housed in an aircontrolled room 25 2 and 50 humidity with a 12-hour light/dark cycle 7:00/19:00 . The mice were fed a standard diet CE-2, Clea Japan, Tokyo, Japan and water ad libitum for 1 week prior to experiments.
The mice were assigned to three groups matched according to body weight: vehicle 0.5 hydroxyethyl cellulose solution , 20 mg/kg oleanolic acid, and 40 mg/kg oleanolic acid. Oleanolic acid was suspended in 0.5 hydroxyethyl cellulose solution. Vehicle 0.5 hydroxyethyl cellulose solution or oleanolic acid was administered by oral gavage once a day at 13:00 for 7 days. The body weight of each mouse was monitored every day, and the cumulative food intake during the experiment period was measured. On day 7, after the final administration, the mice were fasted for 6 h, and blood and the stomach were collected under anesthesia with a mixture of medetomidine, midazolam and butorphanol. Plasma was collected by centrifugation from the blood samples at 2,000 g for 5 min, mixed with a 1/10 volume of 1 mol/L HCl, and stored at 80 until analysis. Plasma octanoylated ghrelin concentrations were measured using the Acylated Ghrelin mouse, rat Express EIA Kit according to the manufacturer s instructions. Animal studies were repeated using mice fed a high-fat diet D12451; Research Diets, New Brunswick, NJ, USA or a high-glucose diet composed of CE-2 and glucose at a weight ratio of 3:2. The proportion of protein, carbohydrate, and fat contained in the standard diet CE-2 and the high-fat diet D12451 is shown in Table 1 . Furthermore, the compositions of fatty acid in these two diets are shown in Table 2 .
The animal studies were approved by the Research Ethics Committee of the Faculty of Pharmaceutical Sciences of Nagasaki International University No. 126 and were conducted in accordance with Ethical Guidelines for Animal Experiments of the Faculty of Pharmaceutical Sciences of Nagasaki International University.
Quantitative reverse transcription-polymerase chain
reaction qRT-PCR To study the mechanism by which oleanolic acid inhibits octanoylated ghrelin production, mRNA levels of mouse ghrelin, GOAT, furin, PC1/3, and PC2 in the stomach tissues were evaluated by qRT-PCR. Total RNA was extracted from each mouse stomach using TRIzol reagent and reverse-transcribed into cDNA using ReverTra Ace. PCR was performed using the CFX Connect Real-Time System Bio-Rad, Tokyo, Japan . The reaction mixture containing 10 μL of 2 SYBR ® Fast qPCR Mix, 0.4 pmol sense and antisense primers, and 2 μL of diluted cDNA was loaded onto a 96-well plate. Amplification was performed under the following conditions: 95 for 30 s, followed by 40 cycles of 95 for 5 s and 60 for 10 s. The sense and antisense primers used in this study are shown in Table 3 . Transcript levels were estimated from the respective standard curves and normalized to the levels of 18S ribosomal Table 1 Standard diet CE-2 and high-fat diet D12451 components used in this study.
Oleanolic Acid Decreases Octanoylated Ghrelin Levels in Mice
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Evaluation of the effect of oleanolic acid on octanoyl
CoA production The Free Fatty Acid Assay Kit was used to evaluate the effect of oleanolic acid on octanoyl-CoA production by measuring the amount of free fatty acids using acyl-CoA synthetase and acyl-CoA oxidase. First, acyl-CoA synthetase catalyzes the fatty acid acylation of CoA. Next, the acyl-CoA product is oxidized by acyl-CoA oxidase, producing hydrogen peroxide which reacts with the colorimetric probe absorbance of 570 nm included in the kit. Accordingly, the amount of a conjugation between fatty acid and CoA is determined by 570 nm. Octanoic acid 100 μmol/L , oleanolic acid 100 μmol/L , or a combination of both compounds was added to a 96-well plate. The assay was performed according to the manufacturer s instructions, and absorbance at 570 nm was determined for each well.
Statistical analysis
Data are presented as means standard deviation SD . Differences among groups were analyzed by ANOVA, followed by Tukey s tests for multiple comparisons. Differences were considered significant at p 0.05.
RESULTS
3.1 Effects of oleanolic acid on plasma octanoylated ghrelin levels, cumulative food intake, and body weight gain Compared to the vehicle group, oleanolic acid 20 and 40 mg/kg significantly reduced plasma octanoylated ghrelin levels and body weight gain p 0.05 in the standard dietfed mice Fig. 2A . Food intake was lower in the oleanolic acid-treated groups than in the vehicle-treated group, but this difference was not significant Fig. 2A .
In contrast to the observed effects in standard diet-fed mice, oleanolic acid had no effects on octanoylated ghrelin levels, cumulative food intake, or body weight gain in highfat or high-glucose diet-fed mice Fig. 2B, 2C .
Effects of oleanolic acid on ghrelin, GOAT, furin,
PC1/3, and PC2 mRNA expression We investigated whether gene expression changes contribute to the decreased levels of octanoylated ghrelin in the plasma. In particular, we examined the expression of genes encoding ghrelin, GOAT, and PCs involved in ghrelin processing in the stomachs of standard diet-fed mice by qRT-PCR. Oleanolic acid 20 or 40 mg/kg had no significant effect on the relative mRNA expression levels of ghrelin, GOAT, furin, PC1/3, and PC2 Fig. 3 .
Effect of oleanolic acid on octanoyl CoA production
We previously showed that the carboxy group mediates the effect of oleanolic acid on octanoylated ghrelin levels 13 .
Octanoyl-CoA, a substrate for the octanoylation of ghrelin by GOAT, is formed by the dehydrocondensation of the octanoic acid carboxy group and CoA thiol group. Therefore, we hypothesized that the binding of oleanolic acid with a carboxy group to CoA may cause a competitive decrease in the production of octanoyl-CoA and reduced levels of octanoylated ghrelin. Hence, we investigated whether oleanolic acid inhibits the production of octanoyl-CoA using the Free Fatty Acid Assay Kit. In the assay, the absorbance of the reaction mixture increases as a complex with CoA is formed. A significant increase in absorbance was observed when octanoic acid was added Fig. 4 . Absorbance in the wells treated with oleanolic acid was nearly identical to that in the control Fig. 4 . The addition of octanoic acid and combined addition of octanoic acid and oleanolic acid resulted in similar increases in absorbance Fig. 4 . Table 2 Fatty acid components in CE-2 and D12451. Table 3 The primers used in this study.
DISCUSSION
Oleanolic acid has anti-obesity effects in mice 14 . In the present study, we found that the oral administration of oleanolic acid significantly decreases plasma octanoylated ghrelin levels and body weight gain without altering cumulative food intake in standard diet-fed mice. There are two noteworthy points regarding these results. First, despite the reduction in plasma octanoylated ghrelin levels, oleanolic acid had no effect on cumulative food intake. Wellman et al. reported that the intraperitoneal injection of a GOAT inhibitor once a day for 4 days decreased food intake for the initial 1 h after re-feeding in 24 h-fasted mice 15 ;
however decreased food intake was not observed after 2 h. These results suggest that the inhibitory effect of decreased octanoylated ghrelin on food intake disappeared over a short period of time. In our study, since the observation period for cumulative food intake was 7 days and mice were not fasted during the period, a decrease in cumulative food consumption may not be detected. In addition, experimental and clinical studies have indicated that the blood concentration of oleanolic acid decreases within several hours after its administration 16 18 . Therefore, the oncedaily administration of oleanolic acid may be insufficient to maintain a low level of octanoylated ghrelin throughout the day. The second point is that oleanolic acid significantly reduced body weight gain in standard-diet fed mice, despite the lack of a difference in cumulative food intake. Octanoylated ghrelin reduces energy expenditure 4 6 ; therefore, increased energy expenditure induced by the reduction of octanoylated ghrelin levels may explain the decreased body weight gain. Previously, de Melo et al. reported that oleanolic acid 10 mg/kg for 15 weeks decreased plasma ghrelin levels and body weight gain in mice 14 . The administration period of their study is much longer but dosage is smaller than those of our study. Although 20 mg/kg of oleanolic acid decreased plasma octanoylated ghrelin level in our study, there is a possibility that 7 days administration of 10 mg/kg of oleanolic acid also reduces plasma octanoylated ghrelin level. Furthermore, de Melo et al. has reported that oleanolic acid increased plasma leptin level in mice 14 . However, we speculate that in our study the change of plasma leptin level is minimal because the administration period of our study was shorter than that of de Melo et al., hence, there were no significant differences in cumulative food intake between control and oleanolic acid-treated mice in our study. Oleanolic acid did not decrease plasma octanoylated ghrelin levels and body weight gain in high-fat diet-fed mice. Our previous study revealed that oleic acid decreases plasma octanoylated ghrelin levels in mice 19 . Oleic acid is the most abundant fatty acid in the high-fat diet D12451 used in this study. Furthermore, ingested medium-chain fatty acids are used directly for ghrelin acylation in mice 20 .
Dietary fatty acids after absorption are mostly present in an ester form. However, some fatty acids are thought to be de-esterified by esterase and form a conjugate with CoA. We consider that a part of oleic acid is also present as oleylCoA in the body of the mouse. Since acyl-CoA is known to be a substrate for acylation of ghrelin, oleyl-CoA may be involved in the inhibition of octanoylated ghrelin production. Therefore, the inhibitory effect of oleanolic acid on octanoylated ghrelin production might have been masked due to the suppression of octanoylated ghrelin production by oleic acid in the high-fat diet. D12451 contains various other fatty acids, and these may also compete with octanoic acid for acylation by GOAT, resulting in decreased octanoylated ghrelin. There is a report showing that plasma octanoylated ghrelin levels in high-fat diet-fed mice are lower than those in standard diet-fed mice 14 , supporting our above-mentioned consideration. Oleanolic acid did not decrease the plasma octanoylated ghrelin levels and body weight gain in high-glucose diet-fed mice as well as high-fat diet-fed mice. Glucose administration has also been reported to reduce plasma ghrelin levels 21 . Therefore, the inhibitory effect of oleanolic acid on octanoylated ghrelin production may be masked by glucose in the high-glucose diet-fed mice as well as by fatty acids in high fat diet-fed mice. Next, we investigated the mechanisms underlying the reduction in octanoylated ghrelin levels by oleanolic acid. We previously reported that -epigallocatechin-3-O-gallate EGCG decreased plasma octanoylated ghrelin levels in mice, and decreased gene expressions of ghrelin and PC1/3 by EGCG may be involved in lowering the octanoylated ghrelin level 22 . Therefore, we investigated the alteration of gene expressions of proteins related to octanoylated ghrelin production caused by oleanolic acid. In standard diet-fed mice, oleanolic acid did not affect the mRNA expression of ghrelin and enzymes such as GOAT, furin, PC1/3, or PC2, involved in octanoylated ghrelin production. In this study, we did not examine the effect of oleanolic acid on the enzymatic activities of GOAT, furin, PC1/3, and PC2. Oleanolic acid does not inhibit GOAT activity 23 , but its effect on other PC activities have not been evaluated. Further studies should investigate the effect of oleanolic acid on PC activities to elucidate the mechanism underlying the inhibition of octanoylated ghrelin production. Our previous in vitro study showed that the carboxy group in triterpenes contributes to the suppression of octanoylated ghrelin production 13 . Octanoyl-CoA, a substrate for GOAT, is formed by dehydrocondensation between the carboxy group in octanoic acid and the thiol group in CoA. If oleanolic acid forms a complex with CoA, the production of octanoyl-CoA may be competitively inhibited and decreased octanoylated ghrelin production may be induced. There was no significant difference in absorbance, a surrogate index for the amount of acyl-CoA, between groups treated with the combination of octanoic acid with oleanolic acid and octanoic acid alone. These data indicate that oleanolic acid did not affect the formation of octanoyl-CoA. For the detection of free fatty acids using the kit used in this study, it is essential to generate hydrogen peroxide and 2,3-trans-enoyl-CoA by the oxidation of acyl-CoA with acyl-CoA oxidase. Since there is no hydrogen neighboring the carboxy group in oleanolic acid, hydrogen peroxide is probably not produced, even if a complex of oleanolic acid and CoA is formed. Although absorbance was not increased by treatment with oleanolic acid in our study, it is not possible to conclude that a complex of oleanolic acid and CoA was not generated. The inhibitory effect of oleanolic acid on octanoylated ghrelin production may not be caused by the decrease in octanoyl-CoA. Long chain fatty acids have been reported to decrease octanoylated ghrelin levels via the action on G-protein coupled receptor 120 GPR120 24 . Furthermore, cisplatin has been revealed to decrease octanoylated ghrelin levels via the action on 5-HT 2 receptor 25 . It is necessary to investigate the involvement of GPR120 or 5-HT 2 receptor-mediated mechanisms underlying the reduction of octanoylated ghrelin by oleanolic acid.
CONCLUSION
We demonstrated that oleanolic acid decreases plasma octanoylated ghrelin levels and body weight gain in standard diet-fed mice. Anti-obesity effects of triterpenes, such as oleanolic acid, have been reported in mice; therefore, the reduction of octanoylated ghrelin levels may contribute to the anti-obesity effect of oleanolic acid. Our findings may provide valuable knowledge for the development of anti-obesity agents with an inhibitory effect on octanoylated ghrelin production. The elucidation of the mechanism underlying the reduction of octanoylated ghrelin levels by oleanolic acid is a future issue.
